How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

The WTA is governed by a set of rules that are consolidated in an annual rulebook. Please click the link below to view the 2025 WTA Official Rulebook WTA Safeguarding Code 2026 Official Rules (PDF) ...

December 24, 2025 • The fight over the soul of higher education is very alive right now, with the Trump administration engaged in dozens of investigations and multiple lawsuits against colleges and ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

The Chicago Manual of Style is an American English style guide published by the University of Chicago Press. The Manual’s guidelines for publishing, style and usage, and citations and indexes—known as ...

India's new labour codes, effective November 21, 2025, consolidate 29 laws, promising universal minimum wages, enhanced social security for gig workers, and improved safety. While offering businesses ...